Stock listing
Dusseldorf:XE7C Cardiff Oncology, Inc. Aktie
German listing (Dusseldorf) of Cardiff Oncology, Inc. · home listing NASDAQ:CRDF
Follow Cardiff Oncology, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:CRDF
$0.912 USD +0.014 (+1.6%)
Close on Oct 29, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:CRDF
- Day range
- $0.900 – $0.950 USDOct 29, 2026
- Volume
- 123,203 sharesOct 29, 2026
- Market cap
- $71.04M USDAt the close on Oct 29, 2026 · price × 77.89M shares outstanding
- 52-week range
- $0.760 – $3.310 USDLowest and highest trades, Oct 30, 2025 – Oct 29, 2026
- Traded on an average day
- $738,331 USDMedian day 574,050 shares · last 3 months, Jul 29, 2026 – Oct 29, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:CRDF · Home | $0.912 USD | +0.014 (+1.6%) | 123,203 | $0.902 | $0.950 | $0.900 | $0.898 | Close on Oct 29, 2026 |
Daily closes
Last 3 months, Jul 29, 2026 – Oct 29, 2026 · NASDAQ:CRDF · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.912 | +0.014 | +1.6% | $0.902 | $0.950 | $0.900 | 123,203 | |
| $0.898 | +0.022 | +2.6% | $0.870 | $0.950 | $0.850 | 280,536 | |
| $0.875 | +0.071 | +8.8% | $0.820 | $0.890 | $0.781 | 637,049 | |
| $0.804 | -0.103 | -11.4% | $0.890 | $0.950 | $0.790 | 866,649 | |
| $0.907 | -0.023 | -2.4% | $0.920 | $0.940 | $0.885 | 174,285 | |
| $0.930 | -0.010 | -1.1% | $0.930 | $0.970 | $0.910 | 228,700 | |
| $0.940 | +0.010 | +1.1% | $0.950 | $0.970 | $0.920 | 436,800 | |
| $0.930 | +0.040 | +4.5% | $0.910 | $0.980 | $0.880 | 595,200 | |
| $0.890 | -0.010 | -1.1% | $0.920 | $0.930 | $0.880 | 425,700 | |
| $0.900 | -0.070 | -7.2% | $0.980 | $0.990 | $0.890 | 515,500 | |
| $0.970 | 0.000 | 0.0% | $0.950 | $1.000 | $0.950 | 453,800 | |
| $0.970 | -0.040 | -4.0% | $1.060 | $1.060 | $0.960 | 412,900 | |
| $1.010 | -0.030 | -2.9% | $1.040 | $1.050 | $1.000 | 504,800 | |
| $1.040 | -0.040 | -3.7% | $1.080 | $1.080 | $1.040 | 377,200 | |
| $1.080 | +0.020 | +1.9% | $1.060 | $1.110 | $1.060 | 297,400 | |
| $1.060 | -0.030 | -2.8% | $1.070 | $1.080 | $1.050 | 541,000 | |
| $1.090 | +0.020 | +1.9% | $1.070 | $1.130 | $1.070 | 457,500 | |
| $1.070 | -0.070 | -6.1% | $1.150 | $1.160 | $1.060 | 384,200 | |
| $1.140 | +0.020 | +1.8% | $1.100 | $1.150 | $1.090 | 451,900 | |
| $1.120 | -0.060 | -5.1% | $1.210 | $1.210 | $1.110 | 628,300 | |
| $1.180 | -0.030 | -2.5% | $1.220 | $1.220 | $1.160 | 298,400 | |
| $1.210 | +0.040 | +3.4% | $1.170 | $1.250 | $1.170 | 564,600 | |
| $1.170 | -0.030 | -2.5% | $1.190 | $1.240 | $1.160 | 353,000 | |
| $1.200 | -0.040 | -3.2% | $1.230 | $1.230 | $1.190 | 377,400 | |
| $1.240 | -0.040 | -3.1% | $1.300 | $1.300 | $1.230 | 563,400 | |
| $1.280 | -0.030 | -2.3% | $1.300 | $1.320 | $1.250 | 596,300 | |
| $1.310 | -0.020 | -1.5% | $1.320 | $1.340 | $1.280 | 590,100 | |
| $1.330 | -0.040 | -2.9% | $1.370 | $1.390 | $1.330 | 518,500 | |
| $1.370 | 0.000 | 0.0% | $1.390 | $1.410 | $1.360 | 476,000 | |
| $1.370 | +0.070 | +5.4% | $1.290 | $1.390 | $1.290 | 737,800 | |
| $1.300 | -0.050 | -3.7% | $1.360 | $1.380 | $1.260 | 1,131,900 | |
| $1.350 | +0.010 | +0.7% | $1.350 | $1.380 | $1.310 | 1,852,300 | |
| $1.340 | +0.030 | +2.3% | $1.420 | $1.510 | $1.310 | 3,168,500 | |
| $1.310 | +0.100 | +8.3% | $1.230 | $1.340 | $1.220 | 2,100,100 | |
| $1.210 | 0.000 | 0.0% | $1.210 | $1.220 | $1.170 | 493,300 | |
| $1.210 | +0.160 | +15.2% | $1.050 | $1.220 | $1.030 | 744,600 | |
| $1.050 | -0.050 | -4.5% | $1.080 | $1.080 | $1.020 | 716,000 | |
| $1.100 | +0.010 | +0.9% | $1.050 | $1.130 | $1.050 | 708,200 | |
| $1.090 | +0.010 | +0.9% | $1.080 | $1.100 | $1.070 | 437,300 | |
| $1.080 | +0.020 | +1.9% | $1.070 | $1.090 | $1.040 | 375,500 | |
| $1.060 | +0.030 | +2.9% | $1.040 | $1.090 | $1.010 | 700,800 | |
| $1.030 | +0.040 | +4.0% | $1.010 | $1.070 | $1.000 | 838,800 | |
| $0.990 | +0.050 | +5.3% | $0.940 | $1.010 | $0.900 | 590,400 | |
| $0.940 | -0.050 | -5.1% | $0.990 | $0.990 | $0.930 | 527,300 | |
| $0.990 | +0.010 | +1.0% | $0.980 | $1.000 | $0.980 | 202,200 | |
| $0.980 | -0.040 | -3.9% | $1.020 | $1.030 | $0.980 | 274,300 | |
| $1.020 | +0.020 | +2.0% | $1.000 | $1.070 | $0.980 | 918,500 | |
| $1.000 | +0.120 | +13.6% | $0.940 | $1.050 | $0.930 | 1,685,300 | |
| $0.880 | -0.030 | -3.3% | $0.930 | $0.930 | $0.880 | 651,900 | |
| $0.910 | +0.010 | +1.1% | $0.910 | $0.920 | $0.870 | 554,200 | |
| $0.900 | +0.010 | +1.1% | $0.890 | $0.910 | $0.880 | 565,800 | |
| $0.890 | -0.010 | -1.1% | $0.900 | $0.930 | $0.870 | 597,100 | |
| $0.900 | -0.060 | -6.2% | $0.950 | $0.960 | $0.900 | 586,900 | |
| $0.960 | -0.020 | -2.0% | $0.980 | $1.020 | $0.960 | 481,200 | |
| $0.980 | -0.010 | -1.0% | $0.990 | $1.060 | $0.960 | 600,000 | |
| $0.990 | -0.060 | -5.7% | $1.000 | $1.130 | $0.940 | 1,288,200 | |
| $1.050 | +0.020 | +1.9% | $1.050 | $1.060 | $1.000 | 826,900 | |
| $1.030 | +0.040 | +4.0% | $0.950 | $1.090 | $0.950 | 1,035,500 | |
| $0.990 | +0.030 | +3.1% | $0.960 | $1.000 | $0.960 | 639,400 | |
| $0.960 | 0.000 | 0.0% | $0.930 | $0.970 | $0.930 | 446,300 | |
| $0.960 | +0.030 | +3.2% | $0.940 | $0.960 | $0.920 | 628,600 | |
| $0.930 | 0.000 | 0.0% | $0.950 | $0.950 | $0.910 | 646,800 | |
| $0.930 | +0.070 | +8.1% | $0.870 | $0.940 | $0.870 | 1,285,000 | |
| $0.860 | +0.010 | +1.2% | $0.860 | $0.880 | $0.830 | 582,300 | |
| $0.850 | +0.040 | +4.9% | $0.790 | $0.870 | $0.780 | 1,385,700 | |
| $0.810 | -0.010 | -1.2% | $0.800 | $0.820 | $0.760 | 1,202,000 |
- Ticker
- Dusseldorf:XE7C
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Oct 27, 2026
Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 34 slides
Calls
Replays
Cardiff Oncology (NASDAQ:CRDF) Q4 2024 Earnings Call
Thu, Feb 27, 2025 · 8:30 PM ET
Watch TranscriptCardiff Oncology (NASDAQ:CRDF) Q2 2024 Earnings Call
Thu, Aug 08, 2024 · 4:30 PM ET
Watch TranscriptCardiff Oncology (NASDAQ:CRDF) Q1 2024 Earnings Call
Thu, May 02, 2024 · 4:30 PM ET
Watch Transcript
Latest news
Cardiff Oncology Appoints Leila Alland, MD, as Interim Chief Medical Officer
Oct 27, 2026
Closed $0.898 (+2.6%) on Oct 28, 2026
Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
Oct 21, 2026
Closed $0.93 (-1.1%) on Oct 22, 2026
Cardiff Oncology and Nerviano Medical Sciences Amend their 2017 Exclusive License Agreement
Sep 14, 2026
Closed $1.31 (+8.3%) on Sep 14, 2026
Cardiff Oncology to Participate in September 2026 Conferences
Sep 2, 2026
Closed $1.06 (+2.9%) on Sep 2, 2026
Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update
Aug 11, 2026
Closed $0.99 (-5.7%) on Aug 12, 2026
Cardiff Oncology Announces $10 Million Registered Direct Offering
Jul 15, 2026
Closed $0.89 (-32.1%) on Jul 15, 2026
Cardiff Oncology Announces Presentation of Positive Results from its Randomized, Controlled Phase 2 Trial of Onvansertib in First-Line RAS-Mutated mCRC at the 2026 ASCO Annual Meeting
Jun 2, 2026
Closed $1.51 (+2.0%) on Jun 2, 2026
Cardiff Oncology to Participate in the Jefferies Global Healthcare Conference
Jun 1, 2026
Closed $1.51 (+2.0%) on Jun 2, 2026
Cardiff Oncology Announces Webcast to Discuss Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC
May 21, 2026
Closed $1.78 (-0.6%) on May 22, 2026
Cardiff Oncology Reports First Quarter 2026 Results and Provides Business Update
May 14, 2026
Closed $1.67 (-3.5%) on May 15, 2026
Financings
Registered direct offering of common stock and warrants
Aug 11, 2026
Closed: US$10M raised · US$1.05 a share · ½ warrant at US$1.31 for 66 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Buyers: Certain officers and directors (731,707 shares and accompanying warrants at $1.435 per share and accompanying warrant)
Insiders: Certain officers and directors are buying 731,707 shares and accompanying warrants at $1.435 per share and accompanying warrant
Use of proceeds: Working capital and general corporate purposes
Decks
Investor Presentation (October 2026)
Investor deck · 34 slides · October 2026
Technical Presentation (June 2026)
Technical · 27 slides · Jun 3, 2026
Investor Presentation (February 2026)
Investor deck · 39 slides · Feb 25, 2026
Investor Presentation (January 2026)
Investor deck · 68 slides · January 2026
Cardiff Oncology, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 25 in the last 12 months · 121 in all · newest Oct 27, 2026 · oldest 2020
- Calls
- 5 calls with a replay · 5 with a transcript · latest Feb 28, 2025
- Decks
- 89 decks · latest October 2026
Where Cardiff Oncology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:CRDF · Home listing | NASDAQ | United States | USD |
| gettex:XE7C | gettex | Germany | EUR |
| LS Exchange:A2P4GU | LS Exchange | Germany | EUR |
| BOATS:CRDF | BOATS | United States | USD |
| Lang & Schwarz:A2P4GU | Lang & Schwarz | Germany | EUR |
| Frankfurt:XE7C | Frankfurt | Germany | EUR |
| Dusseldorf:XE7C · This page | Dusseldorf | Germany | EUR |
| Munich:XE7C | Munich | Germany | EUR |
| Stuttgart:XE7C | Stuttgart | Germany | EUR |
| Tradegate:XE7C | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Cardiff Oncology, Inc.